Showing results (111-120 of 203) with videos related to
Sort By:
Pageof 21
Pharmacoeconomics|June 17, 2003
Direct treatment costs for patients with lung cancer from first recurrence to death in franceAnne-Chantal Braud, Christine Lévy-Piedbois, Pascal Piedbois, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group StudyBenoist Chibaudel, Franck Bonnetain, Qian Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2024
Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data AvailabilityNatansh D Modi, Sandra M Swain, Marc Buyse, et al.Journal of the National Cancer Institute|June 29, 2007
Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trialsCornelis J A Punt, Marc Buyse, Claus-Henning Köhne, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 12, 2026
Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task ForceSylwia Bujkiewicz, Oriana Ciani, Bart Heeg, et al.JNCI Cancer Spectrum|July 31, 2019
A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analysesWanling Xie, Susan Halabi, Jayne F Tierney, et al.European Urology|May 18, 2024
Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate CancerSabine D Brookman-May, Marc Buyse, Stephen J Freedland, et al.Clinical Trials (London, England)|June 12, 2012
A statistical approach to central monitoring of data quality in clinical trialsDavid Venet, Erik Doffagne, Tomasz Burzykowski, et al.European Journal of Cancer (Oxford, England : 1990)|August 11, 2020
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitorsElisabeth Coart, Stefan Suciu, Pierre Squifflet, et al.JAMA Network Open|March 31, 2025
Generalized Pairwise Comparisons to Support Shared Decision-Making in the CODA TrialSamuel Salvaggio, Sarah E Monsell, Patrick J Heagerty, et al.Pageof 21